Avita Medical | 1811094D - Umsatzerlöse

Aktienkurs
1.17
Täglich Wechseln
-0.08 -6.40%
Monatlich
-2.09%
Jährlich
-61.26%
Q1 Prognose
1.23




Der Umsatz Veränderung Datum
Accuray USD 116.17M 14.63M 2024-12
Celltrion KRW 1.33T 0 2026-03
Clinuvel Pharmaceuticals AUD 55.92M 23.66M 2024-06
Cochlear AUD 1.18B 590.35M 2025-12
CSL USD 8.33B 4.79B 2025-12
Cspc Pharmaceutical CNY 6.62B 358.95M 2025-09
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Knight Therapeutics CAD 121.55M 14.19M 2025-09
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Mayne Pharma AUD 212.07M 17.03M 2025-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Nanosonics AUD 102.23M 2.8M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 80.06M 9.27M 2025-09
Pacific Edge NZD 5.94M 4.95M 2025-12
Paradigm Biopharmaceuticals AUD -8K 441.66K 2025-06
Pharma Mar EUR 90.2M 54.5M 2025-12
Polynovo AUD 70.33M 35.75M 2025-12
PYC Therapeutics AUD 11.04M 2.44M 2025-12
Qiagen NV USD 457.38M 6.06M 2025-12
Ramsay Health Care AUD 9.34B 82.2M 2025-12
ResMed USD 1.42B 87.23M 2025-12
Sartorius EUR 927.6M 84.4M 2025-12
Sino Biopharmaceutical CNY 17.57B 4.58B 2025-06
Telix Pharmaceuticals AUD 413.44M 103.71M 2025-12
Tilray USD 217.51M 74.75M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M 2025-09